In order to strengthen the strategic relationship with Indian research institutes and improve academic, research and translational capacities between India and UK, the University of Cambridge had invited applicants for five fixed term, research-oriented University Lectureships for Department of Biotechnology (DBT). Under the esteemed ‘DBT Cambridge Lectureship’ programme, Dr. Ankur Mutreja has been awarded the prestigious position at University of Cambridge.
Dr. Mutreja holds the position of ETEC vaccine project leader at the prestigious Hilleman Laboratories. He was happy about the award being coveted to him and expressed his joy saying, “I am humbled to receive this honour and grateful to the University of Cambridge and the Department of Biotechnology, GoI for considering me for this prestigious position. I will also like to express my gratitude to Hilleman Laboratories for providing me a stimulating and highly motivating environment to enhance my knowledge and expertise through advanced research. I look forward to my continued association with the organization.”
Happy at the achievement of Dr. Mutreja, CEO of Hilleman Laboratories Dr. Davinder Gill said, “We are very proud of Dr. Mutreja’s accomplishment and extend our support through his five year stint at the University of Cambridge. This presents a unique engagement platform wherein we aim to foster strategic alliances across the UK and Europe.” During his five year stint in the lectureship programme, Dr. Mutreja would shift his time working at the UK and the Indian institutes simultaneously. Apart from Dr. Mutreja, four other scientists have been selected for the lectureship programme by the University.